[1]
S. Zeb, “CLOPIDOGREL VERSUS PRASUGREL IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION”, Pak Heart J, vol. 49, no. 3, Nov. 2016.